Drug Profile
BL 1874
Alternative Names: BL 1851Latest Information Update: 05 Dec 2002
Price :
$50
*
At a glance
- Originator Bioglan Pharma [CEASED]
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 05 Dec 2002 Discontinued - Preclinical for Viral infections in United Kingdom (unspecified route)
- 20 Nov 2000 New profile
- 20 Nov 2000 Preclinical development for Viral infections in United Kingdom (Unknown route)